Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Telehealth Advantages : Consult your provider from the convenience of your home, avoiding clinic visits and saving time
Retatrutide (research code LY3437943) is a triple agonist that binds GIP, GLP-1, and glucagon simultaneously, setting it apart from the dual GIP/GLP-1 agonist tirzepatide and the GLP-1 mono-agonist semaglutide
Here's how to build that claim correctly every time
Accessed June 25, 2025.
At this time, the patient received a diagnosis of ischemic colitis resulting from the use of semaglutide and was recommended not to resume the medication
US$ 29.91
US$ 23.57
US$ 26.53
US$ 27.06
US$ 22.15
US$ 26.46
US$ 29.15
US$ 20.44
